Can genomics be used to determine radiation dose?

Understanding if a patient needs a higher or lower dose of radiation in order to kill the tumor cells is the focus of a new paper by Dr. Jacob Scott and colleagues in Dr.Javier Torres-Roca’s lab. Researchers have developed a biomarker profile, a genomic test, to determine how well a tumor will respond to radiation therapy. This profile, called the genomic-adjusted radiation dose (GARD) predicted clinical outcome in breast, lung, glioblastoma, and pancreatic cancer. Lancet Oncology

Contact Dr. Keen


    Your Email*